HILLINA HABTESELASSIE: Open Payments
NPI 1871114157 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,363 in 67 payments from 17 companies in 2025. Trend: 2023 $688 · 2024 $1,088 · 2025 $1,363
Food & beverage: $1,363
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $244 |
| AstraZeneca Pharmaceuticals LP | 7 | $200 |
| Amgen Inc. | 8 | $135 |
| Astellas Pharma US Inc | 4 | $111 |
| Axsome Therapeutics, Inc. | 5 | $98 |
| Lilly USA, LLC | 5 | $87 |
| Xeris Pharmaceuticals, Inc. | 4 | $86 |
| Exact Sciences Corporation | 3 | $84 |
| Boston Scientific Corporation | 2 | $69 |
| ABBVIE INC. | 2 | $47 |
Products named: Ozempic, AIRSUPRA, Veozah, Auvelity, GVOKE HYPOPEN, Cologuard Collection Kit, OTEZLA, FARXIGA.
Industry payments across OH — which companies pay providers there.
